Axsome Therapeutics, Inc
Symbol: AXSM (NASDAQ)
123.80
▼ (-0.26%) -0.320
Company Description:
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Key Stats
- Today's Open: $123.8
- Today's High: $123.8
- Today's Low: $123.8
- Today's Volume: 221
- Yesterday Close: $124.12
- Yesterday High: $128.08
- Yesterday Low: $123.96
- Yesterday Volume: 478.65K
- Last Min Volume: 1
- Last Min High: $123.8
- Last Min Low: $123.8
- Last Min VWAP: $123.8
Company Profile
- Name: Axsome Therapeutics, Inc
- Website: https://www.axsome.com
- Listed Date: 2015-11-19
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001579428
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $6.19B
- Round Lot: 100
- Outstanding Shares: 49.90M
- Asset Type: CS
RECENT FILINGS FOR AXSM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 144 | View |
| 2025-09-02 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-29 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-28 | 144 | View |
| 2025-08-27 | 144 | View |
| 2025-08-26 | 4 | View |
| 2025-08-26 | 144 | View |
| 2025-08-22 | 144 | View |
| 2025-08-20 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | S-8 | View |
| 2025-08-04 | 10-Q | View |
| 2025-08-04 | 8-K | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 144 | View |
| 2025-06-20 | 144 | View |
Latest News on AXSM